림프절 전이가 있는 작은 크기의 유방암 환자에서 종양 크기와 환자 예후 및 예후 관련 인자들과의 연관성
Comparison of Prognosis according to Tumor Size in Small Breast Cancer with Lymph Node Involvement
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Larger tumor size and more extensive lymph node (LN) involvement have been considered independent factors for poor prognosis of breast cancer. We evaluated whether smaller tumor size may be a factor of worse prognosis compared with larger tumor size in small-sized breast cancer with LN involvement. Methods: A retrospective analysis was conducted at a single center for 1,400 patients with small-sized (≤2 cm) and LN involved (N1−N3) breast cancer who underwent radical surgery, had no distant metastases, and were diagnosed between 2004 and 2014. We subdivided their tumor size into four subgroups (T1mi, T1a, T1b, T1c) graded using the 7th American Joint Committee on Cancer staging and two subgroups (T1ab [≤1 cm] and T1c [>1 cm]) divided by tumor size. The relationship between tumor size, prognosis and specific features were analyzed using the Chi-square test, Kaplan-Meier method, and Cox regression analysis. Results: There were significant differences in estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2) and HER2 amplified type among the four subgroups in all patients. Especially, HER2-amplified type also appeared in distribution significantly between the two subgroups in all patients (T1ab [13.0%] vs. T1c [8.0%], p=0.008). The overall survival of the T1N1 staged patients in the smaller-sized tumor group (T1ab) was lower than that of those in the larger-sized group (T1c) (p=0.005). In the multivariate Cox regression analysis of all patients, the T1ab group showed a higher mortality risk compared with the T1c group (adjusted hazard ratio, 2.540; 95% confidence interval, 1.195–5.397; p=0.015). Conclusion: Smaller-sized tumors with LN involvement indicated worse prognosis compared with larger-sized tumors.
Abstract
Purpose: Larger tumor size and more extensive lymph node (LN) involvement have been considered independent factors for poor prognosis of breast cancer. We evaluated whether smaller tumor size may be a factor of worse prognosis compared with larger tumor size in small-sized breast cancer with LN involvement. Methods: A retrospective analysis was conducted at a single center for 1,400 patients with small-sized (≤2 cm) and LN involved (N1−N3) breast cancer who underwent radical surgery, had no distant metastases, and were diagnosed between 2004 and 2014. We subdivided their tumor size into four subgroups (T1mi, T1a, T1b, T1c) graded using the 7th American Joint Committee on Cancer staging and two subgroups (T1ab [≤1 cm] and T1c [>1 cm]) divided by tumor size. The relationship between tumor size, prognosis and specific features were analyzed using the Chi-square test, Kaplan-Meier method, and Cox regression analysis. Results: There were significant differences in estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2) and HER2 amplified type among the four subgroups in all patients. Especially, HER2-amplified type also appeared in distribution significantly between the two subgroups in all patients (T1ab [13.0%] vs. T1c [8.0%], p=0.008). The overall survival of the T1N1 staged patients in the smaller-sized tumor group (T1ab) was lower than that of those in the larger-sized group (T1c) (p=0.005). In the multivariate Cox regression analysis of all patients, the T1ab group showed a higher mortality risk compared with the T1c group (adjusted hazard ratio, 2.540; 95% confidence interval, 1.195–5.397; p=0.015). Conclusion: Smaller-sized tumors with LN involvement indicated worse prognosis compared with larger-sized tumors.
참고문헌 (32)
- Fowble BL, "The influence of young age on outcome in early stage breast cancer", Int J Radiat Oncol Biol Phys, 30, pp.23~33 (1994)
- Slamon DJ, "Human breast cancer: correlation of relapse and survival with amplification of the HER-2", neu oncogene, 1987, pp.235, 177~182
- Perou CM, "Molecular portraits of human breast tumours", Nature, 406, pp.747~752 (2000)
- Greene FL, "AJCC Cancer Staging Manual" (2002), Springer
- Gajdos C, "Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers", Ann Surg, 230, pp.692~696 (1999)
- Lyu Z, "Lymph node metastasis and prognostic analysis of 354 cases of T1 breast cancer", Zhonghua Zhong Liu Za Zhi, 36, pp.382~385 (2014)
- Wo JY, "Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer", J Clin Oncol, 29, pp.2619~2627 (2011)
- Broekhuizen LN, "The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast", Eur J Surg Oncol, 32, pp.502~506 (2006)
- Houvenaeghel G, "Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study", Ann Oncol, 25, pp.623~628 (2014)
- Shoup M, "Predictors of axillary lymph node metastasis in T1 breast carcinoma", Am Surg, 65, pp.748~752 (1999)
- Brenin DR, "Factors correlating with lymph node metastases in patients with T1 breast cancer", Ann Surg Oncol, 8, pp.432~437 (2001)
- Markopoulos C, "Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma", Am Surg, 66, pp.1011~1013 (2000)
- Ko BS, "Risk factor for axillary lymph node metastases in microinvasive breast cancer", Ann Surg Oncol, 19, pp.212~216 (2012)
- Ichizawa N, "Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification", Jpn J Clin Oncol, 32, pp.108~109 (2002)
- Meyer JS, "Pathology and behavior of small breast carcinomas", Semin Diagn Pathol, 16, pp.257~268 (1999)
- Wasif N, "Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes", Ann Surg Oncol, 17, pp.1862~1869 (2010)
- Kasumi F, "The early breast cancer", Nihon Rinsho, 54, pp.1395~1399 (1996)
- Giuliano AE, "Incidence and predictors of axillary metastasis in T1 carcinoma of the breast", J Am Coll Surg, 183, pp.185~189 (1996)
- Jatoi I, "Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis", J Clin Oncol, 25, pp.1683~1690 (2007)
- Pagani O, "Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century", Breast Cancer Res Treat, 117, pp.319~324 (2009)
- Bulut N, "Does estrogen receptor determination affect prognosis in early stage breast cancers?", Int J Clin Exp Med, 8, pp.21454~21459 (2015)
- Sato K, "Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers", Breast Cancer, 23, pp.310~317 (2016)
- Kaplan HG, "T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy", Breast J, 15, pp.454~460 (2009)
- Hyosun Kim, "Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma", 대한외과학회지, 90(1), pp.1~9 (2016), 대한외과학회
- Lauria R, "The prognostic value of lymphatic and blood vessel invasion in operable breast cancer", Cancer, 76, pp.1772~1778 (1995)
- Wang H, "IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas", Breast J, 14, pp.261~267 (2008)
- vant Veer LJ, "Gene expression profiling predicts clinical outcome of breast cancer", Nature, 415, pp.530~536 (2002)
- Hüsemann Y, "Systemic spread is an early step in breast cancer", Cancer Cell, 13, pp.58~68 (2008)
- Sørlie T, "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications", Proc Natl Acad Sci U S A, 98, pp.10869~10874 (2001)
- Schmidt-Kittler O, "From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression", Proc Natl Acad Sci U S A, 100, pp.7737~7742 (2003)
- Schmidt-Ullrich RK, "Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant", Int J Radiat Oncol Biol Phys, 27, pp.545~552 (1993)
- Coburn NG, "A novel approach to T classification in tumor-node-metastasis staging of breast cancer", Am J Surg, 192, pp.434~438 (2006)